domingo, 12 de abril de 2020

On immunotherapy, we've mastered the foothills but the summit lies ahead

On immunotherapy, we've mastered the foothills but the summit lies ahead

First Opinion

Predicting immunotherapy success: We’ve mastered the foothills but the summit lies ahead

By THOMAS DAVIS AND JESSICA FLECHTNER


ADOBE
Immunotherapy is an important new treatment for cancer, but we need better ways to tell whose immune systems are up to the task.

No hay comentarios: